Xoma | XOMA - Sales Revenues

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $25K in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Agenus USD 24.07M 2.77M Mar/2025
Agios Pharmaceuticals USD 19.97M 7.07M Dec/2025
Ardelyx USD 110.33M 12.67M Sep/2025
aTyr Pharma USD 190K 2.03M Sep/2025
BioMarin Pharmaceutical USD 776M 49M Sep/2025
Celldex Therapeutics USD 890K 160K Sep/2025
Curis USD 2.55M 460K Jun/2024
Eli Lilly USD 19.3B 1.7B Dec/2025
Emergent BioSolutions USD 276.6M 6.1M Dec/2023
Incyte USD 1.51B 140M Dec/2025
MacroGenics USD 72.84M 50.6M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Novartis USD 14.36B 478M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Prothena USD 2.42M 2M Sep/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Xoma USD 25K 5M Sep/2024